Page last updated: 2024-09-03

2-chloro-n(6)cyclopentyladenosine and felodipine

2-chloro-n(6)cyclopentyladenosine has been researched along with felodipine in 1 studies

Compound Research Comparison

Studies
(2-chloro-n(6)cyclopentyladenosine)
Trials
(2-chloro-n(6)cyclopentyladenosine)
Recent Studies (post-2010)
(2-chloro-n(6)cyclopentyladenosine)
Studies
(felodipine)
Trials
(felodipine)
Recent Studies (post-2010) (felodipine)
2520431,328421238

Protein Interaction Comparison

ProteinTaxonomy2-chloro-n(6)cyclopentyladenosine (IC50)felodipine (IC50)
Adenosine receptor A3Homo sapiens (human)1.057
Cytochrome P450 2C9 Homo sapiens (human)4.5795
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)1.057
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)1.057
Bile acid receptorHomo sapiens (human)4.96

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Casati, C; Forlani, A; Lozza, G; Monopoli, A1

Other Studies

1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and felodipine

ArticleYear
Hemodynamic changes do not mediate the cardioprotection induced by the A1, adenosine receptor agonist CCPA in the rabbit.
    Pharmacological research, 1997, Volume: 35, Issue:1

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Analysis of Variance; Animals; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Felodipine; Hemodynamics; Male; Myocardial Infarction; Purinergic P1 Receptor Agonists; Rabbits; Vasodilator Agents

1997